News Update on merger EC offered remedy proposal Staff November 20, 2023 Read the full announcement in PDF Attachment Update on merger EC offered remedy proposal Iframe sync Post Navigation Previous Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASHNext Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission. More Stories EHR Healthcare News NextGen Healthcare Welcomes Madison Dearborn Partners as New Investment Partner and Announces Planned Leadership Succession Staff June 6, 2025 Healthcare Hospitals News Patient Care Pharmaceutical Rocketseed launches essential email signature guide for healthcare organizations Staff June 6, 2025 Hospitals News Pharmaceutical Hospital PMI® at 52%; May 2025 Hospital ISM® Report On Business® Staff June 6, 2025
